Profile

JN Nova Pharma is developing novel therapeutics to address a particular group of Long COVID patients, who are affected by respiratory and kidney-related diseases. JN Nova Pharma has completed GMP manufacturing and toxicology studies and is preparing the Clinical Trial Application package for Phase I studies.

JN Nova Pharma Inc. logo

Website

jnnova.com

Contact


Event details

Date: June 3 - 6, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

42 in total